Hedgeye CEO Keith McCullough is adding Dexcom (DXCM) to the short side of Investing Ideas. Below is a brief note.
Looking for more Healthcare "Growth" Shorts? Our Healthcare analyst Tom Tobin remains bearish on Dexcom (DXCM) that bounced to lower-highs on #decelerating volume this week.
Here's an excerpt from Tom's latest Institutional Research note on the name:
|
DXCM - We've been tracking medical claims for interpretation of continuous glucose monitor data along with app downloads. Comparisons are getting tougher from here and through 1Q20. The market freaked out on management commentary about "tough compares" too... |
Sell the bounce,
KM
